Trial intelligence / Profile preview

Probenecid for Infertility in Men With Spinal Cord Injury

NCT05903859Phase 3Recruiting

Sponsor
University of Miami
Start
Jan 2024
Primary completion
May 2027
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of probenecid in infertility (3 arms), sponsored by University of Miami. Primary endpoint: Change in total motile sperm count. Started Jan 2024; status: recruiting.

02

Drugs

probenecid
03

Conditions

infertility

Beyond the preview

Go deeper on NCT05903859.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05903859.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call